Cystamine and cysteamine as inhibitors of transglutaminase activity in vivo.
- Published in:
- Bioscience Reports, 2018, v. 38, n. 5, p. 1, doi. 10.1042/BSR20180691
- By:
- Publication type:
- Article
Works matching AU Jeitner, Thomas M.
Results: 16
1
2
A Trifunctional Theranostic Ligand Targeting Fibroblast Activation Protein-α (FAPα).
- Published in:
- Molecular Imaging & Biology, 2021, v. 23, n. 5, p. 686, doi. 10.1007/s11307-021-01593-1
- By:
- Publication type:
- Article
3
Induction of magnetic resonance-visible lipid in a transformed human breast cell line by tetraphenylphosphonium chloride.
- Published in:
- International Journal of Cancer, 1997, v. 73, n. 4, p. 570, doi. 10.1002/(SICI)1097-0215(19971114)73:4<570::AID-IJC19>3.0.CO;2-D
- By:
- Publication type:
- Article
4
Tetraphenylphosphonium chloride induced mr-visible lipid accumulation in a malignant human breast cell line.
- Published in:
- International Journal of Cancer, 1996, v. 67, n. 1, p. 72, doi. 10.1002/(SICI)1097-0215(19960703)67:1<72::AID-IJC13>3.0.CO;2-E
- By:
- Publication type:
- Article
5
Modulation of MR-visible mobile lipid levels by cell culture conditions and correlations with chemotactic response.
- Published in:
- International Journal of Cancer, 1996, v. 65, n. 2, p. 238, doi. 10.1002/(SICI)1097-0215(19960117)65:2<238::AID-IJC18>3.0.CO;2-9
- By:
- Publication type:
- Article
6
γ-Glutamylamines and neurodegenerative diseases.
- Published in:
- Amino Acids, 2013, v. 44, n. 1, p. 129, doi. 10.1007/s00726-011-1209-3
- By:
- Publication type:
- Article
7
Linking Inflammation and Parkinson Disease: Hypochlorous Acid Generates Parkinsonian Poisons.
- Published in:
- Toxicological Sciences, 2016, v. 151, n. 2, p. 388, doi. 10.1093/toxsci/kfw052
- By:
- Publication type:
- Article
8
Mechanisms for the Cytotoxicity of Cysteamine.
- Published in:
- Toxicological Sciences, 2001, v. 63, n. 1, p. 57, doi. 10.1093/toxsci/63.1.57
- By:
- Publication type:
- Article
9
Central Role of Glutamate Metabolism in the Maintenance of Nitrogen Homeostasis in Normal and Hyperammonemic Brain.
- Published in:
- Biomolecules (2218-273X), 2016, v. 6, n. 2, p. 16, doi. 10.3390/biom6020016
- By:
- Publication type:
- Article
10
The Enzymology of 2-Hydroxyglutarate, 2-Hydroxyglutaramate and 2-Hydroxysuccinamate and Their Relationship to Oncometabolites.
- Published in:
- Biology (2079-7737), 2017, v. 6, n. 2, p. 24, doi. 10.3390/biology6020024
- By:
- Publication type:
- Article
11
Transglutaminases and neurodegeneration.
- Published in:
- Journal of Neurochemistry, 2009, v. 109, p. 160, doi. 10.1111/j.1471-4159.2009.05843.x
- By:
- Publication type:
- Article
12
Increased levels of γ-glutamylamines in Huntington disease CSF.
- Published in:
- Journal of Neurochemistry, 2008, v. 106, n. 1, p. 37, doi. 10.1111/j.1471-4159.2008.05350.x
- By:
- Publication type:
- Article
13
Treatment of YAC128 mice and their wild-type littermates with cystamine does not lead to its accumulation in plasma or brain: implications for the treatment of Huntington disease.
- Published in:
- Journal of Neurochemistry, 2005, v. 94, n. 4, p. 1087, doi. 10.1111/j.1471-4159.2005.03255.x
- By:
- Publication type:
- Article
14
Inhibition of theα-ketoglutarate dehydrogenase complex by the myeloperoxidase products, hypochlorous acid and mono-N-chloramine.
- Published in:
- Journal of Neurochemistry, 2005, v. 92, n. 2, p. 302, doi. 10.1111/j.1471-4159.2004.02868.x
- By:
- Publication type:
- Article
15
Synthesis and Evaluation of 11 C-Labeled Triazolones as Probes for Imaging Fatty Acid Synthase Expression by Positron Emission Tomography.
- Published in:
- Molecules, 2022, v. 27, n. 5, p. 1552, doi. 10.3390/molecules27051552
- By:
- Publication type:
- Article
16
ONCE-DAILY MEMANTINE: PHARMACOKINETIC AND CLINICAL CONSIDERATIONS.
- Published in:
- 2010
- By:
- Publication type:
- Letter